Total Bakkenolides Protects Neurons against Cerebral Ischemic Injury through Inhibition of Nuclear Factor-Κb Activation.

In conclusion, our results provide a strong pharmacological basis for further understanding the potential therapeutic role of total bakkenolides in cerebral ischemic disease and shed new light on its neuroprotective mechanism. PMID: 24040794 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24040794?dopt=Abstract

Source: CNS and Neurological Disorders Drug Targets - August 27, 2013 Category: Drugs & Pharmacology Authors: Jiang Q, Xia Yy EY, Jm HE, Guo Ml EY, Rp LI Tags: CNS Neurol Disord Drug Targets Source Type: research